Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Diagnostics company renews cancer research collaboration with Johns Hopkins
April 14th, 2005
Ciphergen Diagnostics, a division of Ciphergen Biosystems, Inc., (CIPH), announced the renewal of its multiyear research collaboration with the Johns Hopkins University School of Medicine aimed at the discovery of novel protein biomarkers in the field of cancer. The focus of the collaboration over the last 5 years has been to discover and validate new diagnostic biomarkers that may improve cancer detection, classify types of disease, and provide disease monitoring. This collaboration led to the publication in August 2004 in Cancer Research of a study which described the use of Ciphergen's PatternTrack approach to discover three protein biomarkers that form the...
Source: Women's Health Weekly (2005-04-14)
|
